Suppr超能文献

电子健康记录分析表明,在确诊 COVID-19 患者中,肾病是导致住院的首要风险因素。

Electronic health record analysis identifies kidney disease as the leading risk factor for hospitalization in confirmed COVID-19 patients.

机构信息

Geisinger, Danville, Pennsylvania, United States of America.

出版信息

PLoS One. 2020 Nov 12;15(11):e0242182. doi: 10.1371/journal.pone.0242182. eCollection 2020.

Abstract

BACKGROUND

Empirical data on conditions that increase risk of coronavirus disease 2019 (COVID-19) progression are needed to identify high risk individuals. We performed a comprehensive quantitative assessment of pre-existing clinical phenotypes associated with COVID-19-related hospitalization.

METHODS

Phenome-wide association study (PheWAS) of SARS-CoV-2-positive patients from an integrated health system (Geisinger) with system-level outpatient/inpatient COVID-19 testing capacity and retrospective electronic health record (EHR) data to assess pre-COVID-19 pandemic clinical phenotypes associated with hospital admission (hospitalization).

RESULTS

Of 12,971 individuals tested for SARS-CoV-2 with sufficient pre-COVID-19 pandemic EHR data at Geisinger, 1604 were SARS-CoV-2 positive and 354 required hospitalization. We identified 21 clinical phenotypes in 5 disease categories meeting phenome-wide significance (P<1.60x10-4), including: six kidney phenotypes, e.g. end stage renal disease or stage 5 CKD (OR = 11.07, p = 1.96x10-8), six cardiovascular phenotypes, e.g. congestive heart failure (OR = 3.8, p = 3.24x10-5), five respiratory phenotypes, e.g. chronic airway obstruction (OR = 2.54, p = 3.71x10-5), and three metabolic phenotypes, e.g. type 2 diabetes (OR = 1.80, p = 7.51x10-5). Additional analyses defining CKD based on estimated glomerular filtration rate, confirmed high risk of hospitalization associated with pre-existing stage 4 CKD (OR 2.90, 95% CI: 1.47, 5.74), stage 5 CKD/dialysis (OR 8.83, 95% CI: 2.76, 28.27), and kidney transplant (OR 14.98, 95% CI: 2.77, 80.8) but not stage 3 CKD (OR 1.03, 95% CI: 0.71, 1.48).

CONCLUSIONS

This study provides quantitative estimates of the contribution of pre-existing clinical phenotypes to COVID-19 hospitalization and highlights kidney disorders as the strongest factors associated with hospitalization in an integrated US healthcare system.

摘要

背景

需要有关于增加 2019 年冠状病毒病(COVID-19)进展风险的条件的实证数据,以识别高危个体。我们对与 COVID-19 相关的住院相关的预先存在的临床表型进行了全面的定量评估。

方法

对具有系统级门诊/住院 COVID-19 检测能力的综合卫生系统(Geisinger)中 SARS-CoV-2 阳性患者进行了全表型关联研究(PheWAS),并对回顾性电子健康记录(EHR)数据进行了评估,以评估与住院(住院)相关的 COVID-19 大流行前的临床表型。

结果

在 Geisinger 接受 SARS-CoV-2 检测的 12971 个人中,有足够的 COVID-19 大流行前 EHR 数据,其中 1604 人 SARS-CoV-2 阳性,354 人需要住院治疗。我们在 5 种疾病类别中发现了 21 种表型,这些表型达到了全表型显著性(P<1.60x10-4),包括:六种肾脏表型,例如终末期肾病或 5 期 CKD(OR=11.07,p=1.96x10-8),六种心血管表型,例如充血性心力衰竭(OR=3.8,p=3.24x10-5),五种呼吸表型,例如慢性气道阻塞(OR=2.54,p=3.71x10-5)和三种代谢表型,例如 2 型糖尿病(OR=1.80,p=7.51x10-5)。另外基于估计肾小球滤过率定义 CKD 的分析,证实了与预先存在的 4 期 CKD(OR 2.90,95%CI:1.47,5.74),5 期 CKD/透析(OR 8.83,95%CI:2.76,28.27)和肾脏移植(OR 14.98,95%CI:2.77,80.8)相关的住院高风险,但与 3 期 CKD(OR 1.03,95%CI:0.71,1.48)无关。

结论

本研究提供了 COVID-19 住院与预先存在的临床表型之间关系的定量估计,并强调了肾脏疾病是美国综合医疗保健系统中与住院相关的最强因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4609/7660530/3c661debdbe4/pone.0242182.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验